AUTHOREA
Log in Sign Up Browse Preprints

loading page

Successful desensitization after hypersensitivity reaction to cisplatin in a patient with nasopharyngeal carcinoma
  • +1
  • Arisa Kinouchi,
  • Hiroki Ishii,
  • Kaname Sakamoto,
  • Daiju Sakurai
Arisa Kinouchi
University of Yamanashi

Corresponding Author:[email protected]

Author Profile
Hiroki Ishii
University of Yamanashi
Author Profile
Kaname Sakamoto
University of Yamanashi
Author Profile
Daiju Sakurai
University of Yamanashi
Author Profile

Abstract

Hypersensitivity reaction (HSR) to cisplatin can result in discontinuation of chemoradiotherapy in patients with head and neck squamous cell carcinoma (HNSCC). We present a nasopharyngeal carcinoma patient with cisplatin hypersensitivity successfully treated with cisplatin-desensitization. Desensitization therapy may be safe and beneficial in patients with HNSCC who develop HSR to cisplatin.

Peer review status:Published

21 Jun 2022Submitted to Clinical Case Reports
Show details
Hide details
22 Jun 2022Submission Checks Completed
22 Jun 2022Assigned to Editor
02 Jul 2022Reviewer(s) Assigned
17 Jul 2022Review(s) Completed, Editorial Evaluation Pending
01 Aug 2022Editorial Decision: Revise Minor
16 Sep 20221st Revision Received
19 Sep 2022Submission Checks Completed
19 Sep 2022Assigned to Editor
19 Sep 2022Review(s) Completed, Editorial Evaluation Pending
26 Sep 2022Editorial Decision: Accept
Oct 2022Published in Clinical Case Reports volume 10 issue 10. 10.1002/ccr3.6444